Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24 weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 3.40
Day High 3.74
Open:3.48
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Hormone Replacement Therapy Market to Reach USD 20.76 Billion by 2026; Increasing Cases of Hormone-Related Disorders to Augment Growth, states Fortune Business Insights(TM)
- GlobeNewswire - Mon Mar 30, 11:24AM CDT
GlobeNewswire - CMTX
Mon Mar 30, 11:24AM CDT
The global hormone replacement therapy market size is predicted to reach USD 20.76 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period. The increasing cases of hormone-related disorders in both men and women of different age groups will spur demand for hormone replacement therapy, which in turn, will boost the hormone replacement therapy market growth during the forecast period. In addition, the increasing prevalence of disorders such as growth deficiency, thyroid disorders, and others will create new sales opportunities for the market in the forthcoming years.
Approval of Settlement of Canadian AMS Women's Pelvic Mesh Litigation
- CNW Group - Sat Mar 28, 6:00AM CDT
CNW Group - CMTX
Sat Mar 28, 6:00AM CDT
Siskinds LLP, Siskinds, Desmeules s.e.n.c.r.l., Rochon Genova LLP, and Merchant Law Group announced today court approval of a Canada-wide settlement reached in two class actions related to certain women's pelvic mesh devices for treatment of Pelvic Organ Prolapse ("POP") and Stress Urinary Incontinence ("SUI") manufactured and distributed by American Medical Systems Canada Inc. and American Medical Systems, Inc. ("AMS"). The class actions, which were commenced in 2012 against AMS and Endo Pharmaceuticals, allege various injuries associated with AMS' women's pelvic mesh devices.
Global Opioids Market (2019 to 2026) - Featuring Allergan, Boehringer Ingelheim Group and Endo Pharmaceuticals Among Others - ResearchAndMarkets.com
- BusinessWire - Wed Feb 26, 6:45AM CST
BusinessWire - CMTX
Wed Feb 26, 6:45AM CST
The "Opioids Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.08 +69.71% increase
on 03/18/20
Period Open:5.52
Price movement based on the high, low and last over the given period.
5.77 -38.82% decrease
on 03/03/20
-1.99 (-36.05%) decrease
since 02/28/20
3-Month 2.08 +69.71% increase
on 03/18/20
Period Open:4.45
Price movement based on the high, low and last over the given period.
7.10 -50.28% decrease
on 02/25/20
-0.92 (-20.67%) decrease
since 12/27/19
52-Week 1.97 +79.19% increase
on 09/05/19
Period Open:8.03
Price movement based on the high, low and last over the given period.
8.55 -58.71% decrease
on 05/09/19
-4.50 (-56.04%) decrease
since 03/29/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies